TCL Archive NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System December 5, 1997
TCL Archive With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies May 22, 2009
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive ASCO, AACI Ask $1.3 Billion for NCI, Full Funding Of Center Core, Group Grants May 4, 1984
